Skip to main content
← All resources

Case study · With Janssen

An industrial mRNA in vitro transcription case study

A study performed with Janssen and published, using hybrid models to predict IVT performance and guide development toward mRNA yield and integrity targets.

  • mRNA
  • Process development
EXPERIMENTSTRAINING33UNSEEN VALIDATION9ACTIVE-LEARNING ITERATIONS5 ITERATIONSALL ABOVE INTEGRITY LIMIT
  • 9

    Unseen experiments predicted with errors as low as natural batch-to-batch variation

  • 5

    Active-learning iterations lifted every run above the mRNA integrity acceptance limit

  • MgOAc

    Identified as the key differentiator between high and low yield outcomes

The challenge

A complex, sensitive bioprocess

IVT transcription efficiency and product integrity depend on temperature, reagent ratios, material variability and bioprocess control. Exploring these interactions experimentally is time-consuming and costly.

The approach

Model-driven experimentation

A hybrid model was trained and validated, then an active learning strategy guided five experimental campaigns. Shapley value analysis and what-if simulations deepened bioprocess understanding at each iteration.

  • 33 training experiments
  • IVT bioprocess step
  • Shapley driver analysis

Get the full results

Download the full case study, with project outline, analysis, and case results.